Stephen Mayo - Nov 16, 2021 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Stephen L. Mayo
Stock symbol
SRPT
Transactions as of
Nov 16, 2021
Transactions value $
$0
Form type
4
Date filed
11/17/2021, 07:06 PM
Previous filing
Jun 2, 2021
Next filing
Mar 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Award $0 +4.29K $0.00 4.29K Nov 16, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Option (right to buy) Award $0 +8.24K $0.00 8.24K Nov 16, 2021 Common Stock 8.24K $83.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning November 16, 2022.
F2 The option vests in three equal annual installments beginning November 16, 2022.